PMID: 7022349Aug 1, 1981Paper

Growth acceleration following renal transplantation in children less than 7 years of age

Pediatrics
J R IngelfingerR H Levey

Abstract

Of 110 consecutive renal allografts performed at Children's Hospital Medical Center 12 were in 11 patients aged 3 to 7 years. Patient and graft survival and linear growth were evaluated in these 11 children. All 11 are surviving, seven (64%) with functioning allografts 12 to 92 months after transplant. Six of these seven have normal renal function (on alternate day prednisone dose less than 0.7 mg/kg every two days plus daily azathioprine) and all seven have shown catch-up growth, reaching and maintaining normal height for age. An eighth patient, now returned to dialysis, grew from below the third percentile at age 3 years to the 25th percentile at age 8 years, after which renal function deteriorated. Three patients rapidly rejected allografts and have had decreased growth velocity for age. In contrast, although many of the remaining 76 patients who received 98 transplants after age 7 years are growing, none showed accelerated linear growth sufficient to catch up if below the third percentile for age or to cross centile lines if above. Neither the degree of pretransplant bone age retardation nor steroid dose per kilogram accounted for lack of growth acceleration of those more than 7 years of age. Despite small sample size, the ...Continue Reading

Citations

Feb 10, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Francesca Mencarelli, Stephen D Marks
Jul 1, 1992·Baillière's Clinical Endocrinology and Metabolism·O MehlsK Schärer
Aug 26, 1998·Journal of Cardiothoracic and Vascular Anesthesia·L M MontenegroP J Davis
Sep 1, 1990·Annals of Surgery·J S NajarianT E Nevins
Feb 1, 1983·Archives of Disease in Childhood·M BosqueC Chantler
Nov 1, 1988·Archives of Disease in Childhood·L ReesC Chantler
Jan 1, 1996·Archives of Disease in Childhood·H Maxwell, L Rees

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.